CN102552808B - Medicament for treating vaginal bleeding after abortion - Google Patents

Medicament for treating vaginal bleeding after abortion Download PDF

Info

Publication number
CN102552808B
CN102552808B CN 201210013758 CN201210013758A CN102552808B CN 102552808 B CN102552808 B CN 102552808B CN 201210013758 CN201210013758 CN 201210013758 CN 201210013758 A CN201210013758 A CN 201210013758A CN 102552808 B CN102552808 B CN 102552808B
Authority
CN
China
Prior art keywords
medicament
abortion
vaginal bleeding
root
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210013758
Other languages
Chinese (zh)
Other versions
CN102552808A (en
Inventor
张晓林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hundred Sword Pharmaceutical Technology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210013758 priority Critical patent/CN102552808B/en
Publication of CN102552808A publication Critical patent/CN102552808A/en
Application granted granted Critical
Publication of CN102552808B publication Critical patent/CN102552808B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating vaginal bleeding after abortion. The medicament is prepared from the following Chinese herbal medicines: acorus gramineus, turmeric root-tuber, notoginseng root, fructus gardeniae, cattail pollen, thinleaf milkwort root-bark, motherwortherb, pinellia ternata, portulaca oleracea, bupleurum, eclipta alba and sanguisorba officinalis. The medicament is reasonable in formula and exact in curative effects, and can treat the vaginal bleeding after abortion effectively.

Description

A kind of medicament for the treatment of colporrhagia due to abortion
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament for the treatment of colporrhagia due to abortion.
Background technology
Drug induced abortion is widely adopted clinically because of characteristics such as it is safe, effective, convenience.But still have some problems, and as high in the incomplete abortion rate, decidua is discharged slowly, and the colporrhagia time is longer, and amount of bleeding is more etc., and the potential danger that massive hemorrhage is arranged.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of colporrhagia due to abortion.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of colporrhagia due to abortion, it is made by weight by following bulk drugs:
Preferably, it is made by weight by following bulk drugs:
Figure BSA00000659159700012
Preferably, described medicament of the present invention is tablet, dispersible tablet, capsule or decoction.
The reasonable recipe of medicament of the present invention, curative effect is clear and definite, can effectively treat colporrhagia due to abortion.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Rhizoma Acori Graminei 15 grams, Radix Curcumae 30 grams, Radix Notoginseng 15 grams, Fructus Gardeniae 10 grams, Pollen Typhae 15 grams, Radix Polygalae 45 grams, Herba Leonuri 30 grams, the Rhizoma Pinelliae 10 grams, Herba Portulacae 10 grams, Radix Bupleuri 15 grams, Herba Ecliptae 50 grams and Radix Sanguisorbae 30 grams, be placed in 800 ml waters, 90 ℃ of lower reflux 2 hours, filter, obtain filtering residue and filtrate.Described filtrate is concentrated into 500 milliliters, and get final product.
Experimental example
Selection is through drug induced abortion and satisfy following condition person and include investigation in: menolipsis≤49 day, and age≤40 year old, healthy, without intrauterine device, before medicine stream, routine blood test, liver function detect normally, and it is in utero pregnant that Urine HCG positive, B ultrasonic confirm, can follow up a case by regular visits to.Choose patient's 40 examples that meet above-mentioned condition, minimum 22 years old of age, maximum 38 years old, 26.7 years old mean age.
Choosing the decoction of preparation in embodiment 1 treats.Every day 3 times, each 50 milliliters.5 days is 1 course for the treatment of.Inactive other drug during treatment.
Criterion of therapeutical effect
Recovery from illness: clinical symptoms, sign all disappear, and lab testing urine pregnancy tests is negative, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram.Take a turn for the better: clinical symptoms, sign disappear substantially, but do not do urine pregnancy tests and ultrasound diagnosis.Do not heal: clinical symptoms, sign are not improved.
Therapeutic outcome
Described 40 routine patients all meet the standard of recovery from illness after treatment.And do not observe obvious untoward reaction.
After this all the patient was followed up a case by regular visits to weekly in 1 month, found that recurrence does not all appear in all patients.

Claims (2)

1. a medicament for the treatment of colporrhagia due to abortion, is characterized in that, it is to be made by weight by following bulk drugs:
Figure FSB00001033806000011
2. the medicament for the treatment of colporrhagia due to abortion according to claim 1, is characterized in that, it is to be made by weight by following bulk drugs:
Figure FSB00001033806000012
CN 201210013758 2012-01-17 2012-01-17 Medicament for treating vaginal bleeding after abortion Expired - Fee Related CN102552808B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210013758 CN102552808B (en) 2012-01-17 2012-01-17 Medicament for treating vaginal bleeding after abortion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210013758 CN102552808B (en) 2012-01-17 2012-01-17 Medicament for treating vaginal bleeding after abortion

Publications (2)

Publication Number Publication Date
CN102552808A CN102552808A (en) 2012-07-11
CN102552808B true CN102552808B (en) 2013-06-12

Family

ID=46400262

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210013758 Expired - Fee Related CN102552808B (en) 2012-01-17 2012-01-17 Medicament for treating vaginal bleeding after abortion

Country Status (1)

Country Link
CN (1) CN102552808B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840151A (en) * 2006-01-25 2006-10-04 张冬 Pure Chinese medicinal preparation for activating blood circulation, removing blood stasis and relieving pain
CN102139010A (en) * 2011-03-17 2011-08-03 武汉健民中药工程有限责任公司 Traditional Chinese medicine for treating postabortal colporrhagia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840151A (en) * 2006-01-25 2006-10-04 张冬 Pure Chinese medicinal preparation for activating blood circulation, removing blood stasis and relieving pain
CN102139010A (en) * 2011-03-17 2011-08-03 武汉健民中药工程有限责任公司 Traditional Chinese medicine for treating postabortal colporrhagia

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中西医结合治疗经间期出血38例临床观察;许燕;《河北中医》;20090128;第31卷(第01期);81-82 *
李克勤.药物流产后流血的中医治疗近况.《河南中医》.1997,第17卷(第02期),122-120.
药物流产后流血的中医治疗近况;李克勤;《河南中医》;19970420;第17卷(第02期);122-120 *
许燕.中西医结合治疗经间期出血38例临床观察.《河北中医》.2009,第31卷(第01期),81-82.

Also Published As

Publication number Publication date
CN102552808A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
CN101780160A (en) Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof
CN103223155B (en) Medicament for treating postpartum hemorrhage
CN103071018B (en) Traditional Chinese medicine preparation for treating early habitual abortion
CN105832991A (en) Traditional Chinese medicine composition for treating gastritis
CN102488813B (en) Medicine for curing fibroid
CN102078565A (en) Traditional Chinese medicine prescription for treating ectopic pregnancy
CN102552808B (en) Medicament for treating vaginal bleeding after abortion
CN104013704B (en) Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition
CN103191399A (en) Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period
CN101698037B (en) Medicine for treating uterine bleeding and preparation process thereof
CN104784650A (en) Pharmaceutical preparation for clinical nursing of gastric ulcer
CN103566225B (en) Medicament for treating gynecological postoperative gastrointestinal dysfunction
CN103550372B (en) Medicament for medical abortion
CN103349760A (en) Medicine for treating colporrhagia after abortion
CN103751727B (en) A kind of pharmaceutical composition and application thereof for the treatment of ectopic pregnancy
CN103989737A (en) Preparation method for pharmaceutical composition for treating chronic pelvic inflammation
CN105288056A (en) Pharmaceutical composition for treating threatened abortion and preparation method of pharmaceutical composition
CN105250952B (en) A kind of Chinese medicine composition for treating uterus adenomyosis
CN105031552A (en) Traditional Chinese medicine composition for treating gynecological tumors
CN103566077B (en) A kind of medicament for the treatment of hysteromyoma
CN104306708A (en) Medicine for treating spleen deficiency type menstrual period irregularity and application thereof
CN118267427A (en) Traditional Chinese medicine composition for treating blocking antibody abnormality, and pharmaceutical preparation and application thereof
CN104474513A (en) Medicine for treating endometriosis
CN103610929B (en) Preparation method of medicament for treating chronic cervicitis
CN102784167B (en) Pharmaceutical composition for treating viral pneumonia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG

Free format text: FORMER OWNER: ZHANG XIAOLIN

Effective date: 20130805

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 273500 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130805

Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

Address before: Department of Obstetrics and Gynecology thousand Springs Road No. 59, Shandong province people's Hospital of Zoucheng City, Shandong province Zoucheng city 273500

Patentee before: Zhang Xiaolin

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170509

Address after: 226500, No. 999, Wanshou South Road, Rugao City, Jiangsu province (room 3A08-26, building 8, hi tech Zone, Nantong)

Patentee after: Jiangsu hundred sword Pharmaceutical Technology Co., Ltd.

Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130612

Termination date: 20190117

CF01 Termination of patent right due to non-payment of annual fee